Venetoclax and Ibrutinib in Patients With Relapsed/Refractory CLL or SLL
Clinical trial NCT03045328 · COMPLETED
Trial details
- NCT number
- NCT03045328
- Sponsor
- Steven E. Coutre
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-26
- Primary completion
- 2020-05-19
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.